Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Hladun

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 24, 2016
Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer studyFernando Carceller, Francisco J Bautista, Irene Jiménez, et al.
Journal of Neuro-Oncology|December 18, 2017
Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of careTeresa de Rojas, Francisco Bautista, Miguel Flores, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2025
Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European <i>Paediatric</i> Soft Tissue Sarcoma Study Group RMS 2005 TrialGianni Bisogno, Julia Chisholm, Raquel Hladun, et al.
Cancer|July 26, 2024
Localized incompletely resected standard risk rhabdomyosarcoma in children and adolescents: Results from the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 trialHenry C Mandeville, Gianni Bisogno, Veronique Minard-Colin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 8, 2025
Safety and dosimetry of [<sup>177</sup>Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P studyMark N Gaze, Daria Handkiewicz-Junak, Raquel Hladun, et al.
NPJ Precision Oncology|July 2, 2026
Loss of BAX in a neuroblastoma patient reveals delayed apoptosis but sustained chemotherapy sensitivityAdrià Molero-Valenzuela, Isabel de Rojas-P, Guillem Pons, et al.
Nature Communications|October 28, 2020
Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastomaLaura Escudero, Anna Llort, Alexandra Arias, et al.
Head & Neck|November 15, 2024
Parameningeal Rhabdomyosarcoma: Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 StudyReineke A Schoot, Pieter Taselaar, Giovanni Scarzello, et al.
Cellular and Molecular Life Sciences : CMLS|October 11, 2022
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastomaNatalia Navarro, Carla Molist, Júlia Sansa-Girona, et al.
Cancers|October 16, 2025
Childhood, Adolescent and Young Adult Poor-Prognosis RhabdomyosarcomaAjla T Wasti, Gianni Bisogno, Raquel Hladun, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|September 24, 2016
Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer studyFernando Carceller, Francisco J Bautista, Irene Jiménez, et al.
Journal of Neuro-Oncology|December 18, 2017
Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of careTeresa de Rojas, Francisco Bautista, Miguel Flores, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2025
Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European <i>Paediatric</i> Soft Tissue Sarcoma Study Group RMS 2005 TrialGianni Bisogno, Julia Chisholm, Raquel Hladun, et al.
Cancer|July 26, 2024
Localized incompletely resected standard risk rhabdomyosarcoma in children and adolescents: Results from the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 trialHenry C Mandeville, Gianni Bisogno, Veronique Minard-Colin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 8, 2025
Safety and dosimetry of [<sup>177</sup>Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P studyMark N Gaze, Daria Handkiewicz-Junak, Raquel Hladun, et al.
NPJ Precision Oncology|July 2, 2026
Loss of BAX in a neuroblastoma patient reveals delayed apoptosis but sustained chemotherapy sensitivityAdrià Molero-Valenzuela, Isabel de Rojas-P, Guillem Pons, et al.
Nature Communications|October 28, 2020
Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastomaLaura Escudero, Anna Llort, Alexandra Arias, et al.
Head & Neck|November 15, 2024
Parameningeal Rhabdomyosarcoma: Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 StudyReineke A Schoot, Pieter Taselaar, Giovanni Scarzello, et al.
Cellular and Molecular Life Sciences : CMLS|October 11, 2022
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastomaNatalia Navarro, Carla Molist, Júlia Sansa-Girona, et al.
Cancers|October 16, 2025
Childhood, Adolescent and Young Adult Poor-Prognosis RhabdomyosarcomaAjla T Wasti, Gianni Bisogno, Raquel Hladun, et al.
Pageof 3